An organization simply produced kidney and liver tissue in area for the primary time, utilizing a way referred to as bioprinting, which 3D-prints dwelling tissue.
The announcement comes from California-based Auxilium Biotechnologies, whose AMP-1 orbital bioprinter made the breakthrough. The bioprinter used cell and tissue designs from the Wake Forest Institute for Regenerative Medication in North Carolina.
“The flexibility to manufacture a number of tissue sorts alongside clinically related medical merchandise highlights each the flexibility and scalability of our expertise,” Auxilium CEO Jacob Koffler mentioned in an announcement right this moment (July 9).
The experiments came about aboard the Worldwide House Station in June. Along with bioprinting kidney, liver, and cartilage tissues, the AMP-1 machine additionally created 28 nerve restore implants. The bioprinted supplies returned to Earth on a SpaceX Dragon cargo capsule that splashed down within the Pacific Ocean on June 17.
“Efficiently bioprinting dwelling liver and kidney tissue aboard the Worldwide House Station marks an essential step ahead for regenerative medication,” WFIRM director Anthony Atala mentioned in an announcement right this moment (July 9). “The uniform cell distribution achieved aboard the area station factors to actual prospects for manufacturing medical gadgets and tissues in area.”
This wasn’t the primary bioprinting experiment to be carried out on the ISS. For instance, in 2018, Russian cosmonaut Oleg Kononenko examined a machine referred to as the “Bioprinter Organ.Aut,” which efficiently assembled cartilage cells utilizing a magnetic subject.
Nevertheless, Auxilium’s AMP-1 bioprinter is the primary software that has produced a number of sorts of tissue in area, in addition to the primary to make kidney and liver tissue within the last frontier. Auxilium says this flexibility will likely be essential as business pursuits increase manufacturing hubs in area for biotech, healthcare and superior supplies improvement.
“This mission marks an thrilling step ahead for in-space biomanufacturing and demonstrates what could be achieved when modern expertise is paired with robust collaboration,” Isac Lazarovits, Auxilium’s engineering vice chairman, mentioned in the identical assertion.
“Demonstrating a number of product courses and significant manufacturing quantity inside a single mission is a crucial milestone as we proceed advancing towards routine manufacturing operations in orbit,” Lazarovits continued.
